DE3483801D1 - Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel. - Google Patents

Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.

Info

Publication number
DE3483801D1
DE3483801D1 DE8484108229T DE3483801T DE3483801D1 DE 3483801 D1 DE3483801 D1 DE 3483801D1 DE 8484108229 T DE8484108229 T DE 8484108229T DE 3483801 T DE3483801 T DE 3483801T DE 3483801 D1 DE3483801 D1 DE 3483801D1
Authority
DE
Germany
Prior art keywords
effect
hydosanes
mucopolysaccharides
cells
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484108229T
Other languages
English (en)
Inventor
Massimo Baldacci
Ugo Baldacci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratori Baldacci SpA
Original Assignee
Laboratori Baldacci SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Baldacci SpA filed Critical Laboratori Baldacci SpA
Application granted granted Critical
Publication of DE3483801D1 publication Critical patent/DE3483801D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
DE8484108229T 1983-07-13 1984-07-12 Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel. Expired - Fee Related DE3483801D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22045/83A IT1163772B (it) 1983-07-13 1983-07-13 Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
DE3483801D1 true DE3483801D1 (de) 1991-02-07

Family

ID=11190660

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484108229T Expired - Fee Related DE3483801D1 (de) 1983-07-13 1984-07-12 Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.

Country Status (9)

Country Link
US (1) US5470965A (de)
EP (1) EP0134502B1 (de)
JP (1) JPS6038390A (de)
AT (1) ATE59656T1 (de)
AU (1) AU577300B2 (de)
CA (1) CA1277937C (de)
DE (1) DE3483801D1 (de)
IT (1) IT1163772B (de)
ZA (1) ZA845434B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1208509B (it) * 1985-03-13 1989-07-10 Mediolanum Farmaceutici Srl Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908004A (en) * 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2535324A1 (fr) * 1982-10-27 1984-05-04 Choay Sa Station perfectionnee pour l'epuration d'eaux usees
IT1189298B (it) * 1982-06-18 1988-02-04 Manetti & Roberts Italo Brit Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
FR2538404B1 (de) * 1982-12-28 1985-08-23 Anic Spa
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina

Also Published As

Publication number Publication date
IT1163772B (it) 1987-04-08
IT8322045A0 (it) 1983-07-13
JPS6038390A (ja) 1985-02-27
ATE59656T1 (de) 1991-01-15
EP0134502B1 (de) 1991-01-02
ZA845434B (en) 1985-02-27
CA1277937C (en) 1990-12-18
IT8322045A1 (it) 1985-01-13
AU577300B2 (en) 1988-09-22
US5470965A (en) 1995-11-28
EP0134502A1 (de) 1985-03-20
AU3053884A (en) 1985-01-17
JPH0446281B2 (de) 1992-07-29

Similar Documents

Publication Publication Date Title
ATE40555T1 (de) Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.
CA1267495C (en) PURIFICATION AND ACTIVATION OF INSOLUBLE INCLUSION BODY PROTEINS
DE3750733D1 (de) Verfahren zur Herstellung von Hyaluronsäure, dafür benötigte Bakterienstämme und kosmetische Zusammensetzung, welche Hyaluronsäure enthält.
FI851231L (fi) Menetelmä ihmisen interleukiini-2:n talteensaamiseksi
DE3856505D1 (de) Proteine mit Faktor VIII Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende Zusammensetzungen
DE3482812D1 (de) Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3752319D1 (de) Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE10075010I1 (de) Fusionsproteine mit immunglobulinanteilen ihre Herstellung und Verwendung
AU4014589A (en) The alpha-subunit of the lfa-1 leukocyte adhesion receptor
EP0364690A3 (de) Alpha-Subeinheit des Mac-1-Leukocyt-Adhäsions-Rezeptors
ES506347A0 (es) Procedimiento de separacion de mezclas biologicas
DE3767311D1 (de) Thrombin bindender stoff und verfahren zu seiner herstellung.
ATE84554T1 (de) Verfahren zur herstellung von isocyanurat- und urethanbindungen enthaltenden schaeumen.
DE3483801D1 (de) Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.
KR900003207A (ko) 트롬빈 결합성 물질 및 이의 제조방법
ATE22096T1 (de) Vinylencarbonat-polymerisate, verfahren zu ihrer herstellung und ihre anwendung.
ATE33253T1 (de) Verfahren zur herstellung von reinen dermatansulfat- und herapansulfatglykosaminoglukanen und ihre pharmazeutische verwendung.
DE68914236D1 (de) Verfahren zur Herstellung von Natriumhyaluronat durch Gärung.
DE3675855D1 (de) Verfahren zur herstellung von hochmolekularen, gegebenenfalls verzweigten polyarylensulfiden.
ATE113062T1 (de) Throminbindende substanz und verfahren zu ihrer herstellung.
DE68928634T2 (de) Verfahren zur Herstellung von aktivierten Killer-Monozyten und Verfahren zur Überprüfung ihrer tumoriziden Aktivität
ES2082140T3 (es) Procedimiento para obtener proteina celular con actividad anti-hiv.
DE3671906D1 (de) Verfahren zur herstellung von hochmolekularen, gegebenenfalls verzweigten polyarylensulfiden.
IE39669L (en) Purification of indole alkaloids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: BARZ, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 80803 MUENCHEN

8339 Ceased/non-payment of the annual fee